Independence is working with FutureScripts®, an independent
company, to offer a Medication Therapy Management (MTM) program to patients
enrolled in a Medicare Advantage plan. This program ensures that they are
receiving the safest, most effective medications while helping to reduce
out-of-pocket costs.
Program details
A patient is eligible for participation in the MTM program if he or she has
three or more chronic diseases, including:
- bone/joint disease (i.e., osteoporosis or rheumatoid arthritis)
- chronic heart failure
- diabetes
- high cholesterol
- high blood pressure
- mental health issues (i.e., depression)
- respiratory diseases (i.e., asthma or chronic obstruction pulmonary
disease)
Independence patients who qualify will be automatically enrolled in the MTM
program and will receive the following:
- an introduction letter describing the MTM program;
- a full medication review by a specially trained pharmacist, including:
- high-risk medications (for members taking certain medications that have a
high risk of serious adverse effects when there may be safer drug
alternatives);
- medication adherence (for members who are not taking certain diabetes, high
blood pressure, or high cholesterol medicines as prescribed);
- a summary medication review package that contains a medication action
plan;
- telephonic outreach and review at least every three months and an updated
action plan if any changes are necessary.
Medication reviews are offered once a year but may occur more frequently if
a patient is diagnosed with new conditions or prescribed new medications.
Medicare requires that MTM programs automatically enroll anyone who qualifies
during the calendar year; however, participation is voluntary and enrollees
have the opportunity to opt-out at any time. If your patient is automatically
enrolled, they will remain in the program throughout the calendar year unless
they opt-out or change their plan.
If you have any questions regarding this program, please contact the
FutureScripts MTM Department at 1-855-380-1228.